Clinical Trials Browser

Not yet recruiting × Solid Tumor × olaparib × Clear all

NCT05522491 2025-12-11

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumor